25 Remarkable Stories: Palpable Electricity
-
25 Remarkable Stories: Palpable Electricity
Debbie Hart always picks up the phone when PTC calls. As the President and CEO of BioNJ, the life sciences trade association for New Jersey, she has been observing and living through every moment with PTC since the company was founded in 1998, by Stuart Peltz, Founding CEO of PTC, and the partnership with BioNJ.…
-
What’s So Special About 2023?
2023 is a meaningful, unique and thrilling year for PTC. It’s the company’s 25th anniversary, and it is poised to be a year of momentum as we anticipate significant trial readouts in multiple disease areas. We’re also working toward our ambitious goal to produce a therapy every two to three years based on our robust…
-
PTC is a Finalist in Two Pharma Industry Awards in Ireland
PTC was thrilled to be shortlisted as a finalist in the Pharma Industry Awards in two categories, Biotech Company of the Year and Supply Chain Achievement Award, alongside remarkable companies and organizations in Ireland’s pharma industry. The Pharma Industry Awards recognize and celebrate the most original and innovative individuals and companies that demonstrate excellence in…
-
PTC opens office in Poland
On the 1st of September 2022, PTC Therapeutics officially opened it’s the newly established office, located in Warsaw, Poland. The new office marks an important milestone for our company and the patients we serve. PTC’s roots in Poland have already existed for several years, during which we have been invested in supporting the rare disease…
-
PTC Welcomes Alethia Young to the Board of Directors
Alethia Young’s journey to become a PTC Board Member began with a reverence for doctors. When she was young, her grandfather had glioblastoma, which resulted in long stints in the hospital. It was during this time that she began to idolize the doctors and nurses caring for her grandfather, and decided she wanted to become…
-
PTC is in Japan!
Today, 1 April 2022, we celebrate the official opening of PTC’s new office in Japan! Located in the heart of the life sciences industry of Japan – Tokyo, Nihonbashi – our new office adds to PTC’s growing global footprint and extends our reach to support people living with rare diseases around the globe. We sat…
-
Career Opportunity: Executive Director, Global Medical Affairs – Global Gene Therapy Lead
Join the Global Medical Affairs Team and Advance our Gene Therapy Business At PTC Therapeutics, our science-driven #OnePTC team combines our strong clinical and scientific expertise with dedication to using groundbreaking science and new technologies to find innovative ways to treat diseases with high unmet need. Our Global Medical Affairs team drives this mission forward…
-
Make an Impact as PTC’s New Talent Management Specialist
At PTC Therapeutics, our deeply committed #onePTC team helps us achieve our mission to help extend life’s moments for patients with rare diseases and their loved ones. Part of this success is driven by our dedication to investing in our employees – and our Talent Acquisition team wants to continue to build and expand our…
-
PTC in 2021: A Year of Expansion
For PTC, 2021 was about expansion – not just literally, as we grew our global reach and added team members, but what we can do for patients, too, through our awareness efforts and continued dedication to scientific innovation. Expansion by definition is the act of becoming larger or more extensive. And in fact, we had so much good news in 2021, it was hard for us to pick the highlights to include…
-
Targeting the Regulation of Protein Production for New Medicines
The complexity of protein production associated with protein disorders, especially from faulty genes, is formidable. But that hasn’t stopped PTC from innovating in the space of RNA targeting for novel medicines. In 2003, PTC discovered the first novel small molecule capable of suppressing premature termination of translation by allowing the ribosome to selectively read through…